Nasopharyngeal carcinoma MRI

Jump to navigation Jump to search

Nasopharyngeal carcinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Nasopharyngeal carcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Nasopharyngeal carcinoma MRI On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Nasopharyngeal carcinoma MRI

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Nasopharyngeal carcinoma MRI

CDC on Nasopharyngeal carcinoma MRI

Nasopharyngeal carcinoma MRI in the news

Blogs on Nasopharyngeal carcinoma MRI

Directions to Hospitals Treating Nasopharyngeal carcinoma

Risk calculators and risk factors for Nasopharyngeal carcinoma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Homa Najafi, M.D.[2]Faizan Sheraz, M.D. [3]

Overview

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include [complication 1], [complication 2], and [complication 3].

MRI

There are no MRI findings associated with [disease name].

OR

[Location] MRI may be helpful in the diagnosis of [disease name]. Findings on MRI suggestive of/diagnostic of [disease name] include:

  • [Finding 1]
  • [Finding 2]
  • [Finding 3]

OR

There are no MRI findings associated with [disease name]. However, a MRI may be helpful in the diagnosis of complications of [disease name], which include:

  • [Complication 1]
  • [Complication 2]
  • [Complication 3]

Overview

Head and neck MRI may be helpful in the diagnosis of nasopharyngeal carcinoma. Findings on MRI suggestive of nasopharyngeal carcinoma include dural thickening and bone marrow infiltration.

MRI

MRI may be diagnostic of nasopharyngeal carcinoma. Findings on MRI scan suggestive of nasopharyngeal carcinoma include:[1]

MRI Component Features
T1
  • Typically isointense to muscle
T1 C+ (Gd)
  • Fat saturation in post contrast sequencse
  • Notable heterogeneous enhancement is typical
  • Perineural extension should be sought
T2
  • Isointense to hyperintense to muscle
  • Fat saturation
  • Fluid in the middle ear can be helpful
  • The protocol for routine MRI of a nasopharyngeal mass includes:
    • Unenhanced T1- weighted axial and sagittal plane images for:
      • Detection of skull base invasion
    • T2-weighted fast spin-echo sequence in axial plane images for:
      • Evaluation of early parapharyngeal tumor spread
      • Invasion to the paranasal sinus
      • Effusions of the middle ear
      • Detection of cervical lymph nodes.
    • Contrast-enhanced T1-weighted axial and coronal planes images (with and without fat suppression) for:
    • Evaluation of tumor extension to the perineural and intracranial space.
  • Additional MRI component:
    • Diffusion-weighted imaging for:
      • differentiating NPC from lymphoma
      • characterizing of cervical lymphadenopathy
    • MRI spectroscopy for:
      • Differentiating of the NPC and metastatic nodes from normal neck muscle.

MRI is an accurate test for the diagnosis of NPC. MRI depicts subclinical cancers missed at endoscopy and endoscopic biopsy and identifies patients who do not have NPC and who therefore do not need to undergo invasive sampling biopsies. NPCs usually present with intermediate signal intensity, higher than the muscle signal, on T2-weighted images, low signal intensity on T1- weighted images, and enhance to a lesser degree than does normal mucosa. Eighty-two percent of NPCs arise in the posterolateral recess of the pharyngeal wall (Rosenmüller fossa), and 12% arise in the midline. In 6–10% of patients, the nasopharyngeal mucosa appears normal at endoscopy

References

Template:WikiDoc Sources